Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Retina Care 360 > Manual OCTA resegmentation improves CNV detection in neovascular AMD
  • Retina Care 360

Manual OCTA resegmentation improves CNV detection in neovascular AMD

Ophthalmology 360

Key Takeaways

  1. Manual resegmentation improved OCTA sensitivity for detecting choroidal neovascularization from 68% to 88% while maintaining 100% specificity.
  2. Combining SD-OCT with manually resegmented OCTA achieved the highest diagnostic accuracy, outperforming the combination of SD-OCT and fluorescein angiography.

Manual resegmentation of optical coherence tomography angiography (OCTA) images improved detection of choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD), increasing diagnostic sensitivity to a level comparable with standard imaging modalities, according to a study.

Researchers compared multimodal imaging, including fluorescein angiography (FA), spectral-domain optical coherence tomography (SD-OCT), and OCTA, in patients with nAMD. In patients with unilateral disease, the fellow eye with dry AMD (n = 39) was also evaluated to assess diagnostic sensitivity and specificity. OCTA images with inaccurate automated segmentation caused by retinal distortion underwent manual resegmentation.

Spectral-domain optical coherence tomography demonstrated 86% sensitivity and 100% specificity for diagnosing nAMD, while FA achieved 82% sensitivity and 100% specificity. Automatically segmented OCTA had lower sensitivity at 68%, although specificity remained 100%. After manual resegmentation, OCTA sensitivity increased to 88% while maintaining 100% specificity.

Diagnostic accuracy was highest when SD-OCT was paired with manually resegmented OCTA, compared with the combination of SD-OCT and FA, though both methods showed strong performance.

Reference
Asanad S, Thomspon J. Clinical Value of Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration. J Clin Med. 2026 Jun 27;15(13):5013. doi: 10.3390/jcm15135013. PMID: 42452475.

Share

Related Content

  • Retina Care 360

Cooling anesthesia device reduces pain during intravitreal injections

  • Retina Care 360

Physical activity shows mixed effects on visual outcomes in type 2 diabetes

  • Retina Care 360

Google searches for retinal detachment rose markedly in the United States

  • Retina Care 360

Air pollution linked to higher global AMD burden

  • Retina Care 360

Quiz: Mental health risks linked to age-related eye disease

  • Retina Care 360

Cost analysis shows greater losses for pediatric versus adult retinal detachment repairs

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon